Long-Term Hormonal Treatment for Recurrent Catamenial Pneumothorax

Ozgul Muneyyirci‐Delale, Malini D. Persad, Hena Tewari, Charles Bowers, Jed Cutler
In: Journal of Endometriosis · 2011 · vol. 3(3) , pp. 174–176 · doi:10.5301/je.2011.8913 · W2206294809
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-26 ⓘ

This report describes two patients with endometriosis-associated catamenial pneumothorax who experienced no recurrence during extended norethindrone acetate treatment, suggesting long-term hormonal therapy is a highly efficacious management strategy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Catamenial pneumothorax is a rare complication of endometriosis. Although fatal, no long-term therapies have been revealed to be efficacious in preventing this disorder. This report discusses two cases of catamenial pneumothorax managed with norethindrone acetate over an extended period of time. The patients responded well without recurrence of pneumothorax during treatment. While current therapies are generally used for a six month to one year period, we present a long-term, highly efficacious, and inexpensive treatment for catamenial pneumothorax in patients with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK